Long-term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: A single-center study of 22 patients
Haddad E, Le Diest F, Aucouturier P et al. Long-term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: a single-center study of 22 patients. Blood 1999; 94: 2923-2930.
Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency
Buckley RH, Schiff SE, Schiff RI et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999; 340: 508-516.
Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency
Rubocki RJ, Parsa JR, Hershfield MS et al. Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency. Blood 2001; 97: 809-811.
Application of interphase FISH on direct bone marrow smears for evidence of chimerism in pediatric sex mismatched bone marrow transplantation
Smith A, Robson LG, Sharma P et al. Application of interphase FISH on direct bone marrow smears for evidence of chimerism in pediatric sex mismatched bone marrow transplantation. Pathology 1999; 31: 25-28.
Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: Implications for timely detection of engraftment, graft failure and rejection
Dubovsky J, Daxberger H, Fritsch G et al. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection. Leukemia 1999; 13: 2060-2069.
Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the bioview (Duet™) combined morphological and cytogenetic analysis
Shimoni A, Nagler A, Kaplinsky C et al. Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the bioview (Duet™) combined morphological and cytogenetic analysis. Leukemia 2002; 16: 1413-1418.
Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the Duet™ (BioView) combined morphological and cytogenetics analysis
Trakhtenbrot L, Reichrat M, Shimoni A. Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the Duet™ (BioView) combined morphological and cytogenetics analysis. Leukemia 2002; 16: 1419-1422.
Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation
Bertrand Y, Landis P, Fridrich W et al. Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation. J Pediatr 1999; 134: 740-748.